Server:Microsoft-IIS/7.5...
X-Powered-By:ASP.NET
The main IP address: 46.20.113.246,Your server United States,New York City ISP:Peer 1 Network Enterprises Limited TLD:uk CountryCode:US
The description :menu home about us who we are what we do our team types of clinical trials quality care and clinical governance for patients the first step understanding clinical trials at sarah cannon clinical trial...
This report updates in 15-Jun-2018
Created Date: | 2010-02-22 |
Changed Date: | 2016-01-22 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host sarahcannonresearch.co.uk. Currently, hosted in United States and its service provider is Peer 1 Network Enterprises Limited .
Latitude: | 40.71427154541 |
Longitude: | -74.005966186523 |
Country: | United States (US) |
City: | New York City |
Region: | New York |
ISP: | Peer 1 Network Enterprises Limited |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Microsoft-IIS/7.5 containing the details of what the browser wants and will accept back from the web server.
Content-Length: | 12788 |
Content-Encoding: | gzip |
Set-Cookie: | ASP.NET_SessionId=zbdjx52soyosbsxkwwvmpjlg; path=/; HttpOnly |
X-AspNet-Version: | 4.0.30319 |
Vary: | Accept-Encoding |
X-Powered-By: | ASP.NET |
Server: | Microsoft-IIS/7.5 |
Cache-Control: | private |
Date: | Fri, 15 Jun 2018 04:10:22 GMT |
Content-Type: | text/html; charset=utf-8 |
soa: | ns1.medcity.net. ehc.hostmaster.ehc.com. 527439941 1200 180 1209600 3600 |
ns: | ns2.medcity.net. ns1.medcity.net. |
ipv4: | IP:46.20.113.246 ASN:13768 OWNER:COGECO-PEER1 - Cogeco Peer 1, CA Country:GB |
mx: | MX preference = 20, mail exchanger = backupmail.hcahealthcare.co.uk. MX preference = 10, mail exchanger = mail.hcahealthcare.co.uk. |
menu home about us who we are what we do our team types of clinical trials quality care and clinical governance for patients the first step understanding clinical trials at sarah cannon clinical trials faqs insurance information you and your rights for doctors working with scri uk patient referrals our partners faqs for industry working partnerships facility fact sheet sarah cannon network sarah cannon footprint faqs molecular profiling personalised medicine molecular diagnostics contact us contact us maps and directions join our team comments & complaints general general news news archive sitemap terms & conditions of use video checkmate 067 trial for patients with advanced melanoma combi-d study for patients with metastatic melanoma dr hendrik-tobias arkenau dr howard a. skip burris the embraca clinical trial personalising treatment in breast cancer 020 3219 5200 [email protected] advancing therapies for patients call sarah cannon email us follow us follow us find a clinical trial find cancer type open and recruiting --phase i --colorectal --diffuse large b-cell lymphoma --cll --melanoma --gastric --nhl --prostate --breast --ovarian --lung --renal --bladder --multiple myeloma --pancreas --solid tumours --solid tumours --endometrial --cervix --esophageal upcoming studies --phase i --gastric --cll --solid tumours --breast --ovarian --lung --pancreas --melanoma --follicular lymphoma advancing therapies for patients clinical trials – the first step in fighting cancer powered by partnerships find a clinical trial find cancer type open and recruiting --phase i --colorectal --diffuse large b-cell lymphoma --cll --melanoma --gastric --nhl --prostate --breast --ovarian --lung --renal --bladder --multiple myeloma --pancreas --solid tumours --solid tumours --endometrial --cervix --esophageal upcoming studies --phase i --gastric --cll --solid tumours --breast --ovarian --lung --pancreas --melanoma --follicular lymphoma for patients at sarah cannon, there has been a legacy of devotion to cancer research. our team of collaborating scri sites have enrolled thousands of patients onto clinical trials. learn more for doctors by inhabiting the intersection where cutting-edge research meets compassionate care, we are redefining the standard for quality and excellence in oncology around the world. learn more for partners balancing science, care and commitment, sarah cannon is proud to promote partnership with community physicians and academic institutions. learn more latest videos watch the latest videos. learn more learn more news news from the industry. read more all rights reserved. sitemap | terms & conditions of use | privacy notice sarah cannon research institute united kingdom © copyright 2013 - 2018.
http://www.sarahcannonresearch.co.uk///about-us/types-of-clinical-trials/
http://www.sarahcannonresearch.co.uk///about-us/who-we-are/
http://www.sarahcannonresearch.co.uk///general/sitemap/
http://www.sarahcannonresearch.co.uk///for-doctors/working-with-scr-uk/
http://www.sarahcannonresearch.co.uk///for-industry/faqs/
http://www.sarahcannonresearch.co.uk///general/
http://www.sarahcannonresearch.co.uk///terms-and-conditions-of-use/
http://www.sarahcannonresearch.co.uk///about-us/quality-care-and-clinical-governance/
http://www.sarahcannonresearch.co.uk///for-doctors/faqs/
http://www.sarahcannonresearch.co.uk///for-industry/sarah-cannon-footprint/
http://www.sarahcannonresearch.co.uk///contact-us/comments-and-complaints/
http://www.sarahcannonresearch.co.uk///for-patients/insurance-information/
http://www.sarahcannonresearch.co.uk///video/dr-hendrik-tobias-arkenau/
http://www.sarahcannonresearch.co.uk///for-industry/sarah-cannon-network/
http://www.sarahcannonresearch.co.uk///video/checkmate-067-trial-for-patients-with-advanced-melanoma/
hcahealthcare.co.uk
hcahospitals.co.uk
ucl.ac.uk
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain name:
sarahcannonresearch.co.uk
Registrant:
HCA Information Technology and Services
Registrant type:
Non-UK Corporation
Registrant's address:
2555 Park Plaza
Bldg 3-2
Nashville
TN
37203
United States
Data validation:
Nominet was not able to match the registrant's name and/or address against a 3rd party source on 19-Jan-2013
Registrar:
Markmonitor Inc. t/a MarkMonitor Inc. [Tag = MARKMONITOR]
URL: http://www.markmonitor.com
Relevant dates:
Registered on: 22-Feb-2010
Expiry date: 22-Feb-2018
Last updated: 22-Jan-2016
Registration status:
Registered until expiry date.
Name servers:
ns1.medcity.net
ns2.medcity.net
WHOIS lookup made at 04:18:11 10-Nov-2017
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REFERRER http://www.nominet.org.uk
REGISTRAR Nominet UK
SERVERS
SERVER co.uk.whois-servers.net
ARGS sarahcannonresearch.co.uk
PORT 43
TYPE domain
OWNER
ORGANIZATION HCA Information Technology and Services
TYPE
Non-UK Corporation
ADDRESS
2555 Park Plaza
Bldg 3-2
Nashville
TN
37203
United States
Data validation:
Nominet was not able to match the registrant's name and/or address against a 3rd party source on 19-Jan-2013
DOMAIN
SPONSOR Markmonitor Inc. t/a MarkMonitor Inc. [Tag = MARKMONITOR]
CREATED 2010-02-22
CHANGED 2016-01-22
STATUS
Registered until expiry date.
NSERVER
NS1.MEDCITY.NET 199.91.33.20
NS2.MEDCITY.NET 199.91.36.20
NAME sarahcannonresearch.co.uk
DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .